ReviewProtoplasma2025
Cellular strategies for surviving the alpine extremes: methylerythritol phosphate pathway-driven isoprenoid biosynthesis and stress resilience.
Review in Protoplasma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Impact of Dry and Rainy Seasons on the Chemical Profile and Antioxidant Activity ofMolecules (Basel, Switzerland) · 2026Article
- Spring cold stress at high altitudes in southeastern Xizang activatesHorticulture research · 2026Article
- Secondary metabolism is not secondary-why we need more cell biology in metabolomics.Protoplasma · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High altitude conditions pose a significant challenge to all earth's inhabitants including flora. Low atmospheric pressure (thin air), intense ultraviolet (UV) light, and ultra-low temperatures combine to cause oxidative stress in plants. In these abiotic stress conditions, plants exhibit various ecophysiological, morphological, and biochemical adaptations to cope with stress. Morphologically, plants may develop smaller, thicker leaves with protective trichomes or waxy cuticles against intense UV radiation, and minimize water loss in the thin, dry air. However biochemically, plants increase the production of UV-absorbing compounds like flavonoids and phenolic acids along with antioxidant enzymes for neutralizing reactive oxygen species (ROS). To protect against these stress conditions plants start producing specialized metabolites, i.e., isoprenoids, phenolic acids, flavonoids, sterols, carotenoids, etc. The production of these specialized metabolites occurs through MEP (methylerythritol phosphate) and MVA (mevalonic acid) pathways. Although, this article aims to review the scientific complexities of high-altitude plants by providing an in-depth explanation of the MEP pathway, including its regulation, sources and causes of oxidative stress in plants, functions and roles of isoprenoids in stress tolerance, and the adaptation strategies that support alpine plant survival and acclimation. The MEP pathway's products, several carotenoids, viz., phytoene, lycopene, β-carotene, etc., and terpenoids, viz., geraniol, citral, phytol, etc., act as potent scavengers of ROS, providing defense against oxidative damage. Also, phytohormones, viz., abscisic acid, salicylic acid, and jasmonic acid play crucial roles in modulating plant responses to oxidative stress. To date, little scientific literature is available specifically on high-altitude plants with respect to MEP pathway and oxidative stress management. Understanding the interaction between the MEP pathway and oxidative stress in high-altitude plants can provide insight into the implications for improving crop resilience and producing bioactive chemicals with potential human health benefits.
Indexed as
Identifiers
40180685What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.